Certified by Founder Lodge
23andMe
United States - Sunnyvale, California
INVESTOR
2 Disclosed Funding Rounds $76,500,000
5 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
23andMe, headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 10 ,2022 | Unknown | $6,500,000.00 | |
| October, 18 ,2022 | Series A | $70,000,000 |
| Company | Date | Round | Raised |
|---|---|---|---|
 Exer Health |
November, 10 ,2022 | Unknown | $6,500,000 |
 Prenuvo |
October, 18 ,2022 | Series A | $70,000,000 |
 Helium Health |
June, 06 ,2023 | Series B | $30,000,000 |
 Eureka Health |
July, 13 ,2023 | Unknown | $7,000,000 |
 Forta |
January, 18 ,2024 | Series A | $55,000,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
